Fabry Disease: New Diagnosis of a Family
DOI:
https://doi.org/10.24950/CC/268/20/1/2021Keywords:
alpha-Galactosidase, Fabry Disease, Rare DiseasesAbstract
Fabry’s disease is a rare inherited disease, linked to the X chromosome, that results from a deficiency of alfa‐galactosidase A activity. We report the case of a 59-year-old -man admitted in the emergency department after a fall herald by chest pain. Cardiac ultrasound showed exuberant left ventricle hypertrophy and complementary study with cardiac magnetic resonance showed intramyocardial fibrosis. The rest of the study also showed a proteinuria of 2.15 g/24 hours. Past medical history highlighted an ischemic stroke at 50 years- -old and vasospastic angina at 52 years-old. He also reported many years of symptoms compatible with acroparesthesias and had angiokeratomas since childhood. Suspecting Fabry’s disease, we measured the blood levels of alpha-galactosidase A, which showed a severe reduction in enzyme activity, confirming the diagnosis. Genetic study showed the p.G35E mutation in the alpha-galactosidase gene in our patient, his three daughters and one grandchild.
Downloads
References
Winchester B, Young E. Biochemical and genetic diagnosis of Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 18.
Weidemann F, Sanchez-Niño MD, Politei J, Oliveira JP, Wanner C, Warnock D, et al. Fibrosis: a key feature of Fabry disease with potential therapeutic implications. Orphanet J Rare Dis. 2013;8:116. doi: 10.1186/1750-1172-8-116.
Perretta F, Antongiovanni N, Jaurretche S. Major Organic Involvement in Women with Fabry Disease in Argentina. ScientificWorldJournal. 2018;2018:6515613. doi: 10.1155/2018/6515613.
Juchniewicz P, Kloska A, Tylki-Szymanska A, Jakóbkiewicz-Banecka J, Wegrzyn G, Moskot M, et al. Female Fabry disease patients and X-chromosome inactivation. Gene. 2018;641:259-64. doi: 10.1016/j.gene.2017.10.064.
Lidove O, Kaminsky P, Hachulla E, Leguy-Seguin V, Lavigne C, Marie I, et al.F abry disease the New Great Imposter: results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet. 2012;81:571-7. doi: 10.1111/j.1399-0004.2011.01718.x.
Arends M, Wanner C, Hughes D, Mehta A, Oder D, Watkinson OT, et al. Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study. J Am Soc Nephrol. 2017;28:1631-41. doi: 10.1681/ASN.2016090964.
Akpinar ÇK, Türker H, Bayrak O, Cengiz N. Electroneuromyographic Features in Fabry Disease: A Retrospective Review. Noro Psikiyatr Ars. 2015;52:258-62. doi: 10.5152/npa.2015.7646.
Ínan R, Mese M, Bicik Z. Multidisciplinary approach to Fabry disease: from the eye of a neurologist. Acta Neurol Belg. 2020;120:1333-9. doi: 10.1007/s13760-019-01138-y.
Yagita Y, Sakai N, Miwa K, Ohara N, Tanaka M, Sakaguchi M, et al. Magnetic Resonance Imaging Findings Related to Stroke Risk in Japanese Patients With Fabry Disease. Stroke. 2019;50:2571-3. doi: 10.1161/STROKEAHA.119.025528.
Vardarli I, Rischpler C, Herrmann K, Weidemann F. Diagnosis and Screening of Patients with Fabry Disease. Ther Clin Risk Manag. 2020;16:551-8. doi: 10.2147/TCRM.S247814.
Linhart A, Germain DP, Olivotto I, Akhtar MM, Anastasakis A, Hughes D, et al. An expert consensus document on the management of cardiovascular manifestations of Fabry disease. Eur J Heart Fail. 2020;22:1076-96. doi: 10.1002/ejhf.1960.
Kitani Y, Nakagawa N, Sakamoto N, Takeuchi T, Takahashi F, Momosaki K, et al. Unexpectedly High Prevalence of Coronary Spastic Angina in Patients With Anderson-Fabry Disease. Circ J. 2019;83:481-4. doi: 10.1253/circj.CJ-18-0734.
Cho SC, Yoo HW, Lee JW, Jang JY, Heo R, Song JM. Fabry Disease Presenting with Hypertrophic Cardiomyopathy and Tricuspid Regurgitation. J Cardiovasc Ultrasound. 2016;24:324-8. doi:10.4250/jcu.2016.24.4.324.
Waldek S, Feriozzi S. Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?. BMC Nephrol. 2014;15:72. doi: 10.1186/1471-2369-15-72.
van der Veen SJ, Hollak CEM, van Kuilenburg ABP, Langeveld M. Developments in the treatment of Fabry disease. J Inherit Metab Dis. 2020;43:908-21. doi: 10.1002/jimd.12228.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna